Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-17

Clinical Trial Update: Efficacy of Guanfacine and Lidocaine Combination in Trigeminal Nerve Block for Pain Management in Trigeminal Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial by Vanderbilt evaluated a guanfacine and lidocaine combination delivered via trigeminal nerve block for trigeminal neuralgia; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Trigeminal Neuralgia | Phase 2 | Status: COMPLETED | Results posted: 2024-10-17